
Protective Antibody Responses to Influenza A/H1N1/09 Vaccination in Children With Celiac Disease
Author(s) -
Schäppi Michela G.,
Meier Sara,
Bel Michael,
Siegrist ClaireAnne,
PosfayBarbe Klara M.
Publication year - 2012
Publication title -
journal of pediatric gastroenterology and nutrition
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.206
H-Index - 131
eISSN - 1536-4801
pISSN - 0277-2116
DOI - 10.1097/mpg.0b013e318248e7be
Subject(s) - medicine , disease , vaccination , titer , antibody titer , antibody response , immunology , pandemic , antibody , influenza vaccine , covid-19 , infectious disease (medical specialty)
Patients with celiac disease have an increased risk for severe influenza infection and they show less of a response to certain vaccine types. During the influenza A/H1N1/09 pandemic, we prospectively investigated pandemic vaccine responses in 14 pediatric patients with celiac disease and age‐/sex‐matched controls. All of the children with celiac disease reached protective antibody titers (≥40) and showed a geometric mean titer comparable with the control group (530 vs 573).